Understanding very early onset inflammatory bowel disease (VEOIBD) in relation to inborn errors of immunity
- PMID: 38115672
- PMCID: PMC11044353
- DOI: 10.1111/imr.13302
Understanding very early onset inflammatory bowel disease (VEOIBD) in relation to inborn errors of immunity
Abstract
Inflammatory bowel diseases (IBD) are multifactorial diseases which are caused by the combination of genetic predisposition, exposure factors (environmental and dietary), immune status, and dysbiosis. IBD is a disease which presents at any age, ranging from newborns to the elderly. The youngest of the pediatric IBD population have a more unique presentation and clinical course and may have a different etiology. Very early onset IBD (VEOIBD) patients, designated as those diagnosed prior the age of 6, have distinct features which are more frequent in this patient population including increased incidence of monogenetic causes for IBD (0%-33% depending on the study). This proportion is increased in the youngest subsets, which is diagnosed prior to the age of 2. To date, there are approximately 80 monogenic causes of VEOIBD that have been identified and published. Many of these monogenic causes are inborn errors of immunity yet the majority of VEOIBD patients do not have an identifiable genetic cause for their disease. In this review, we will focus on the clinical presentation, evaluation, and monogenic categories which have been associated with VEOIBD including (1) Epithelial cell defects (2) Adaptive immune defects, (3) Innate Immune/Bacterial Clearance and Recognition defects, and (4) Hyperinflammatory and autoinflammatory disorders. We will highlight differential diagnosis of VEOIBD presentations, as well as evaluation and treatment, which will be helpful for those who study and care for VEOIBD patients outside of the pediatric gastroenterology field. This is a fast-moving field of research which has grown significantly based on knowledge that we gain from our patients. These scientific findings have identified novel mucosal biology pathways and will continue to inform our understanding of gastrointestinal biology.
Keywords: T cells; autoinflammatory process; epithelial cells; inflammatory bowel disease; monogenic; very early onset inflammatory bowel disease.
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Conflict of interest statement
CONFLICT OF INTEREST STATEMENT
No competing interests.
Figures
Similar articles
-
Expanding Contributions of Monogenic Very Early Onset Inflammatory Bowel Disease.Inflamm Bowel Dis. 2021 Oct 20;27(11):1870-1872. doi: 10.1093/ibd/izab145. Inflamm Bowel Dis. 2021. PMID: 34525210 Free PMC article.
-
Clinical Phenotypes and Outcomes in Monogenic Versus Non-monogenic Very Early Onset Inflammatory Bowel Disease.J Crohns Colitis. 2022 Sep 8;16(9):1380-1396. doi: 10.1093/ecco-jcc/jjac045. J Crohns Colitis. 2022. PMID: 35366317 Free PMC article.
-
Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.Inflamm Bowel Dis. 2020 May 12;26(6):820-842. doi: 10.1093/ibd/izz259. Inflamm Bowel Dis. 2020. PMID: 31833544 Free PMC article. Review.
-
Variants in STXBP3 are Associated with Very Early Onset Inflammatory Bowel Disease, Bilateral Sensorineural Hearing Loss and Immune Dysregulation.J Crohns Colitis. 2021 Nov 8;15(11):1908-1919. doi: 10.1093/ecco-jcc/jjab077. J Crohns Colitis. 2021. PMID: 33891011 Free PMC article.
-
Understanding inborn errors of immunity: A lens into the pathophysiology of monogenic inflammatory bowel disease.Front Immunol. 2022 Sep 29;13:1026511. doi: 10.3389/fimmu.2022.1026511. eCollection 2022. Front Immunol. 2022. PMID: 36248828 Free PMC article. Review.
Cited by
-
Improving bench-to-bedside translation for acute graft-versus-host disease models.Dis Model Mech. 2025 Feb 1;18(2):DMM052084. doi: 10.1242/dmm.052084. Epub 2025 Feb 28. Dis Model Mech. 2025. PMID: 40019007 Free PMC article. Review.
-
Advances in Understanding Intestinal Homeostasis: Lessons from Inflammatory Bowel Disease and Monogenic Intestinal Disorder Pathogenesis.Int J Mol Sci. 2025 Jun 26;26(13):6133. doi: 10.3390/ijms26136133. Int J Mol Sci. 2025. PMID: 40649913 Free PMC article. Review.
-
The impact of genetic immune disorders on infections including COVID-19, inflammatory bowel disease and cancer.Nat Immunol. 2025 Sep;26(9):1440-1452. doi: 10.1038/s41590-025-02225-4. Epub 2025 Jul 28. Nat Immunol. 2025. PMID: 40721512 Review.
-
Very Early-Onset IBD-Associated IL-18opathy Treated with an Anti-IL-18 Antibody.J Clin Med. 2024 Oct 11;13(20):6058. doi: 10.3390/jcm13206058. J Clin Med. 2024. PMID: 39458007 Free PMC article.
-
Predictive, preventive and personalised approach as a conceptual and technological innovation in primary and secondary care of inflammatory bowel disease benefiting affected individuals and populations.EPMA J. 2024 Feb 9;15(1):111-123. doi: 10.1007/s13167-024-00351-x. eCollection 2024 Mar. EPMA J. 2024. PMID: 38463620 Free PMC article. Review.
References
-
- Herzog D, Fournier N, Buehr P, et al. Prevalence of intestinal complications in inflammatory bowel disease: a comparison between paediatric-onset and adult-onset patients. Eur J Gastroenterol Hepatol. 2017;29:926–931. - PubMed
-
- Uhlig HH, Charbit-Henrion F, Kotlarz D, et al. Clinical genomics for the diagnosis of monogenic forms of inflammatory bowel disease: a position paper from the Paediatric IBD Porto Group of European Society of Paediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr. 2021;72:456–473. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources